Logo image of PATH

UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PATH - US90364P1057 - Common Stock

16.39 USD
-0.28 (-1.68%)
Last: 12/31/2025, 8:22:53 PM
16.35 USD
-0.04 (-0.24%)
After Hours: 12/31/2025, 8:22:53 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PATH. PATH was compared to 276 industry peers in the Software industry. PATH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PATH is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make PATH a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PATH had positive earnings in the past year.
In the past year PATH had a positive cash flow from operations.
PATH had negative earnings in each of the past 5 years.
In multiple years PATH reported negative operating cash flow during the last 5 years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.93%, PATH belongs to the top of the industry, outperforming 80.07% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.93%, PATH is in the better half of the industry, outperforming 75.36% of the companies in the same industry.
PATH has a Return On Invested Capital of 0.88%. This is in the better half of the industry: PATH outperforms 61.96% of its industry peers.
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROIC 0.88%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin of PATH (14.79%) is better than 77.54% of its industry peers.
Looking at the Operating Margin, with a value of 1.52%, PATH is in the better half of the industry, outperforming 61.96% of the companies in the same industry.
With an excellent Gross Margin value of 83.35%, PATH belongs to the best of the industry, outperforming 89.49% of the companies in the same industry.
PATH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

PATH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PATH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PATH has more shares outstanding
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 5.60 indicates that PATH is not in any danger for bankruptcy at the moment.
PATH has a Altman-Z score of 5.60. This is in the better half of the industry: PATH outperforms 75.36% of its industry peers.
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.6
ROIC/WACC0.08
WACC10.99%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.65 indicates that PATH has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.65, PATH is doing good in the industry, outperforming 71.38% of the companies in the same industry.
A Quick Ratio of 2.65 indicates that PATH has no problem at all paying its short term obligations.
PATH has a Quick ratio of 2.65. This is in the better half of the industry: PATH outperforms 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.65
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

7

3. Growth

3.1 Past

PATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
PATH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 88.99% yearly.
The Revenue has grown by 10.05% in the past year. This is quite good.
PATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.58% yearly.
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%

3.2 Future

Based on estimates for the next years, PATH will show a small growth in Earnings Per Share. The EPS will grow by 1.84% on average per year.
PATH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.61% yearly.
EPS Next Y26.57%
EPS Next 2Y19.6%
EPS Next 3Y15.7%
EPS Next 5Y1.84%
Revenue Next Year11.23%
Revenue Next 2Y10.42%
Revenue Next 3Y9.84%
Revenue Next 5Y11.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.10, the valuation of PATH can be described as rather expensive.
Based on the Price/Earnings ratio, PATH is valued a bit cheaper than the industry average as 69.20% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PATH to the average of the S&P500 Index (26.51), we can say PATH is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 21.22, the valuation of PATH can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PATH indicates a somewhat cheap valuation: PATH is cheaper than 72.46% of the companies listed in the same industry.
PATH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.1
Fwd PE 21.22
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as PATH.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PATH indicates a somewhat cheap valuation: PATH is cheaper than 71.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.94
EV/EBITDA 171.52
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PATH's earnings are expected to grow with 15.70% in the coming years.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y19.6%
EPS Next 3Y15.7%

0

5. Dividend

5.1 Amount

No dividends for PATH!.
Industry RankSector Rank
Dividend Yield 0%

UIPATH INC - CLASS A

NYSE:PATH (12/31/2025, 8:22:53 PM)

After market: 16.35 -0.04 (-0.24%)

16.39

-0.28 (-1.68%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)03-10 2026-03-10/amc
Inst Owners71.21%
Inst Owner Change-22.14%
Ins Owners8.08%
Ins Owner Change3.47%
Market Cap8.70B
Revenue(TTM)1.55B
Net Income(TTM)229.66M
Analysts67.14
Price Target16.43 (0.24%)
Short Float %11.18%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.54%
Min EPS beat(2)7.4%
Max EPS beat(2)83.69%
EPS beat(4)4
Avg EPS beat(4)31.39%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)29.9%
EPS beat(12)12
Avg EPS beat(12)80.56%
EPS beat(16)16
Avg EPS beat(16)90.76%
Revenue beat(2)2
Avg Revenue beat(2)2.34%
Min Revenue beat(2)2.11%
Max Revenue beat(2)2.57%
Revenue beat(4)3
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)9
Avg Revenue beat(12)2.16%
Revenue beat(16)13
Avg Revenue beat(16)2.46%
PT rev (1m)19.07%
PT rev (3m)22.76%
EPS NQ rev (1m)-2.12%
EPS NQ rev (3m)1.08%
EPS NY rev (1m)1.37%
EPS NY rev (3m)1.96%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.1
Fwd PE 21.22
P/S 5.6
P/FCF 27.94
P/OCF 25.98
P/B 4.52
P/tB 4.88
EV/EBITDA 171.52
EPS(TTM)0.68
EY4.15%
EPS(NY)0.77
Fwd EY4.71%
FCF(TTM)0.59
FCFY3.58%
OCF(TTM)0.63
OCFY3.85%
SpS2.92
BVpS3.62
TBVpS3.36
PEG (NY)0.91
PEG (5Y)N/A
Graham Number7.45
Profitability
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROCE 1.12%
ROIC 0.88%
ROICexc 2.63%
ROICexgc 3.28%
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
FCFM 20.06%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 153.76%
Cap/Sales 1.51%
Interest Coverage 250
Cash Conversion 863.81%
Profit Quality 135.66%
Current Ratio 2.65
Quick Ratio 2.65
Altman-Z 5.6
F-Score8
WACC10.99%
ROIC/WACC0.08
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y26.57%
EPS Next 2Y19.6%
EPS Next 3Y15.7%
EPS Next 5Y1.84%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%
Revenue Next Year11.23%
Revenue Next 2Y10.42%
Revenue Next 3Y9.84%
Revenue Next 5Y11.61%
EBIT growth 1Y114.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.12%
EBIT Next 3Y32.64%
EBIT Next 5Y22.63%
FCF growth 1Y28.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.4%
OCF growth 3YN/A
OCF growth 5YN/A

UIPATH INC - CLASS A / PATH FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


What is the valuation status of UIPATH INC - CLASS A (PATH) stock?

ChartMill assigns a valuation rating of 4 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


What is the profitability of PATH stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for PATH stock?

The Price/Earnings (PE) ratio for UIPATH INC - CLASS A (PATH) is 24.1 and the Price/Book (PB) ratio is 4.52.


What is the earnings growth outlook for UIPATH INC - CLASS A?

The Earnings per Share (EPS) of UIPATH INC - CLASS A (PATH) is expected to grow by 26.57% in the next year.